home · filing · 0001773751-23-000015
8-K filed February 23, 2023, 6:59 PM ET
ticker HIMS
CIK 0001773751
leadership
confidence high
sentiment neutral
materiality 0.20
Hims & Hers appoints Christiane Pendarvis to board of directors
Hims & Hers Health, Inc.
Board expanded from 10 to 11 directors; Pendarvis fills newly created vacancy effective Feb 16, 2023.
Pendarvis, 52, deemed independent under NYSE and SEC rules; no committee assignment yet.
She will serve until the 2023 annual meeting; compensation per standard director program.
No family relationships with any director or executive officer; no transactions requiring disclosure.
Pendarvis will enter the company's standard indemnification agreement.
Executive movements
Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements .
Effective 2023-02-16
Filed February 23, 2023, 6:59 PM ET
appointed Christiane Pendarvis, 52, to fill the newly created vacancy, effective February 16, 2023.
Key facts
Extracted from this filing and checked against the source text.
Executive change
SEC 8-K Item 5.02
confidence 0.95
Christiane Pendarvis was appointed as director at Hims & Hers Health, Inc..
Action appointed
Role director
Exact text from the filing
appointed Christiane Pendarvis, 52, to fill the newly created vacancy, effective February 16, 2023.
View on SEC.gov
Source: SEC EDGAR
accession 0001773751-23-000015
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.